We are an organization that amalgamates and International science events for the benefit of the global scientific community. The organization was established in the year 2007 with the sole aim of providing a platform for "Open Access" to the research information pertaining to diversified fields of Science and technology. We published that can be easily accessed online without paying any subscription charges. Our organization plays an instrumental role in expanding the reach of research data in the real time, which in turn helps in furthering the research. Research Scholars, Students, Libraries, Educational Institutions, Research centres and industries are the main stakeholders that are benefitted from open access to research data. We also organize 3000+ across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.
Dear Colleagues,
Conference Series welcome you to the webinar ”4th Asia Pacific Oncology and Cancer Conference” during February 10-11, 2022 London, UK with a theme “Explore the Latest Innovative Treatment and Prevention of Oncology and Cancer Challenges”.
Cancer Summit 2022, webinar will focus on educational research directed toward its impact on clinical outcomes through oral and poster presentations, educational workshop sessions and influential plenary presentations. Cancer Summit 2022 is a perfect platform to find out how Cancer and Oncology research innovations helpful to the Medical, Health and human society. Cancer Summit 2022 will mainly focus on the trending topics during presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of Cancer, Oncology and medical sectors. This includes prompt Keynote Presentations, Oral Talks, Poster Presentations, Video Presentations and Exhibitions.
Overview of Oncology and Cancer:
The Innovative idea of Cancer has started great many researches to be embraced by the labs around the world. An extraordinary number of researchers and scientists taking a shot at Caner research, till date, no significant solution for this is recorded. Global Cancer will also provide two days of discussions on techniques and systems identified with administration and quality change of Cancer and in addition to investigate the new thoughts and ideas on worldwide scale and the themes incorporate lung malignancy, bosom disease, bone tumour, leukaemia, blood cancer, cervical tumour, colon-rectum disease, paediatric malignancy, surgical tumour, Prostate growth, thyroid malignancy.
Global market is segmented into Europe, North America, Latin America, Asia Pacific, Middle East and Africa. According to market study, Market Value for Oncology will be more than double to $ 623 Million by 2020. A major part of the research is going on the top Universities across the globe. So many companies are associated with various Cancer Screening and Diagnostics instruments and other therapeutics. Besides this various societies, associations and research centres are also associated in this research field.
Target Audience:
Cancer Pharmaceutical Companies
Research scholars
Pathologist
Students
Diagnostics companies
Medical Practitioners
Industrial Researchers
Academicians
Directors, Head of Department
Chemotherapists
Research and Development Department.
Business Delegates
Medical Colleges
Rehabilitation Specialists
Genetic scientists
Cancer Associations
Diagnostic Laboratory Professionals
Hospital presidents/CEOs/COOs/VPs/trustees
Hospital c-suite executives (operations, development, finance)
Oncology specialists (medical, radiation, and surgical)
Oncology program and practice administrators, managers, and service line executives
Healthcare consultants, vendors, and suppliers
Cancer program marketing and public relations professionals
Exhibitors and people with keen interest in the research areas of Cancer Research.
Who should sponsor/exhibit:
Basic and Translational Laboratory Researchers
Hospitals
Educational Institutes
Research Centres
Charitable Foundations focused on funding research, advocating for and supporting the needs
Why to attend?
Oncology and Cancer will enlighten the people with the most recent advancements in Cancer diagnosis, Cancer Science, Cancer therapy, Cancer treatment etc., around the world and to glow the related research ideas regarding Cancer Research & Oncology.
The aim of the webinar is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.
Benefits of Attending the Webinar:
Networking Opportunities, Grow Your Professional Network
Build Your Knowledge Base
Expand Your Resources
Learning in a New Space
Break Out of Your Comfort Zone
New Tips & Tactics
Top Industries Representation
Abstracts will be published in the webinar souvenir and respective International journals
Each Abstract will receive unique (DOI) Number provided by Cross Ref
Website visibility to more than 35K visitors in less than 6 months
Laudable talks by the top-notch of the Global Scientific Community
The Serendipity of the Random Workshop
Will be felicitated with International Organizing Committee Member (IOCM)
Remarkable Awards and Global Recognition to meritorious Researchers
Track 1: Fields of Oncology
Oncology/Cancer is the branch of medicine that researches, identifies and treats cancer. A physician works in the field of oncology/Cancer is an oncologist.
Oncologists must first diagnose cancer, which is usually carried out via biopsy, endoscopy, X-ray, CT scanning, MRI, PET scanning, ultrasound or other radio logical methods. Nuclear medicine techniques can also be used to diagnose cancer as can blood tests or tumour markers. Oncology is often linked with haematology. Oncology, which is the branch of medicine that deals with blood and blood-related disorders.
Track 2: Types of Oncology
Oncology is the study of tumour or cancer. Most of the tumours are not cancerous. The cancerous tumours are called malignant tumours. Commonly oncology implies the study of malignant tumours or cancer. The doctor who practices oncology is an oncologist. There are different kinds of oncologists. Those who practiced in surgery are called surgical oncologists. Those who practiced in radiation therapy are called radiation oncologists. Those who practiced in the care of persons with cancer and administer chemotherapy are medical oncologists.
Track 3: Solid tumour
An abnormal mass of tissue and cells that generally does not contain cysts or liquid areas. Solid tumours may be benign Tumours (not cancer), or malignant (cancer). Different categories of solid tumours are named for the type of cells. Some of the examples of solid tumours are sarcomas, carcinomas, and lymphomas. Leukaemia’s (cancers of the blood) usually do not form solid tumours.
One common carcinoma is adrenocortical carcinoma. This is when a tumour progresses in one or both adrenal glands, located above each kidney.
Track 4: Neurosurgical Oncology
Neurosurgical Oncology is a complex surgical method that presupposes treatment, diagnosis, and rehabilitation of disorders affecting any region of the Nervous System. Some of the preponderance is common Neuro surgeries are skull base surgery, Image Guided Surgery, Laser Surgery, Spinal Neurosurgery and Neuro surgical treatment.
Track 5: Nursing Oncology
A Nursing Oncology will gives care to growth patients and those are in danger for getting the sickness. They screen physical conditions, recommend solution and oversee chemotherapy and many medications for cancer. Oncology and Cancer is a standout among the most crucial and remunerating fields in nursing. One of the crucial parts of the cancer nurture is quiet appraisal. They are in charge of surveying patients who have initiated because of treatment reactions, and also evaluating patients, amid and post-chemotherapy. The oncology nurture necessary to have the capacity to comprehend pathology comes about and their suggestions, and have an inside and out learning of the normal symptoms of growth medicines. The oncology nurture like to utilize her relational aptitudes to tune in to the patient, surveying their comprehension of the malady and its procedure and also the patient's passionate state.
Track 6: Medical & Radiation Oncology
Radiation Oncology enclosed all aspects of research that impacts the treatment of oncology using radiation. Radiotherapy can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may be used palliative, to relieve symptoms in patients with incurable cancers. Radiotherapy is expensively segmented into Radiotelegraphy, Brachy-radiotherapy and Metabolic Radiotherapy.
Track 7: Neuro Oncology
The Central Nervous System is denounced to various malevolent personality disorders. Central Nervous System covers its mechanism, Metastatic pestilence, Ramification, Cancers, Neurons and Sensory Receptors, Neurological Disorders, Multiple sclerosis and Imaging agents to CNS neurofibromatosis. Cancer spreads to the Nervous System by direct invasion or compression from continuous tissues relates to the proximity of the Nervous System to other structures. Central Nervous System Drugs market to grow at a CAGR of -3.2% over the period 2013-2018. The central nervous system (CNS) therapeutics peddle has been forecast to reach US$133 billion by the year 2018, which increases in disease ubiquity rates due to increase in population, introduction of new drugs, and increased outgo on healthcare.
Track 8: Brain Tumour
Brain Tumour develops when abnormal cells form inside the brain. The symptoms of Brain stem tumours vary greatly and can involve Ataxia, Cranial Nerve Palsy, headaches, problems with speech and swallowing, hearing loss, weakness, Hemiparesis, vision abnormalities, ptosis, and behavioural changes. Another possible symptom is vomiting. Any brain tumour is inherently serious and life-threatening because of its infiltrative character in the limited space of the Intracranial Cavity.
Track 9: Cancer Cell Biology and genetics
Due to Cancers millions of death occurring every year. The study of cancer biology is one of the largest areas of scientific interest. Cancer cells progress specific hallmarks through a series of mutations in both oncogenes and tumour-suppressor genes. There is no definitive cure for cancer, the most of the cancer treatments serve to prolong the lives of cancer sufferers.
Track 10: Cancer Biomarkers
A Cancer biomarker refers to a substance that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted a particular response of the body to the presence of cancer. Genetic, epigenetic, proteomic and imaging biomarkers can be utilized for cancer diagnosis, prognosis, and epidemiology. Ideally, likewise biomarkers can be assayed in non-invasively collected bio fluids like blood or serum.
Track 11: Cancer metabolomics
Cancer metabolomics research is being used to discover diagnostic cancer biomarkers in the clinic, to better understand its complex heterogeneous nature, to discover pathways involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. Cancer metabolomics approaches may also provide clues to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate goal of most Cancer Metabolomics studies is to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient.
Track 12: Organ-Defined Cancers
Cancer can occur anywhere in the body. The most common sites of cancer among men involve lung, prostate, colon, rectum, stomach, Brain and liver. Those for among women are breast, colon, rectum, lung, cervix, ovarian and stomach. Cancers are often described by the body part that originated in. Some body parts contain multiple types of tissue, so for greater precision, cancers can additionally be classified by the type of cell that the tumour cells originated from. The type of cancer a person has needed to be known properly as many types of cancer can behave very differently and respond to different treatments.
Track 13: Cancer: Psychological Aspects
If one is fighting cancer, it is common to experience psychological distress. Whether it is coping with the diagnosis, the challenges of treatment or continued worry about a recurrence, emotions brought on by the cancer experience can be crucial to handle.
Track 14: Lifestyle Changes to Improve Your Cancer Care
How we live can have profound effects on our health and wellness. This also applies for people who have cancer. A healthy lifestyle can support cancer treatments and help you to cure better. It may also improve your long-term health.
Track 15: Cancer Epigenetics and Oncogenomics
Cancer is a genetic disease affected by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The ambition of oncogenomics is to determined new oncogenes or tumour suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies like Gleevec, Herceptin and a vast in raised the hope for oncogenomics to elucidate new targets for cancer treatment.
Track 16: Cancer Screening and Diagnostics
Cancer screening tests goal to find cancer early, before it causes symptoms and when it may be easier to treat successfully. Effective screening tests are those that:
Reduce the chance that someone who screened regularly will die from cancer.
Have more potential benefits than harms. (Possible harms of screening tests include bleeding or other physical damage, inaccurate test results, and over diagnosis—the diagnosis of cancers that would not have caused problems and did not need treatment.)
Diagnosing cancer at its earliest stages often provides the best chance for a cure.
For few cancers, studies show screening tests can save lives by diagnosing cancer early. For other cancers, screening tests are recommended only for people with increased risk of their life.
Track 17: Cancer Vaccines
Cancer vaccines generally either treat existing cancer or prevent development of cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells and pure antigens. Sometimes a patient’s own immune cells are removed and naked to these substances in the lab to create the vaccines.
Tracks 18: Clinical Trials in Cancer Treatment
Before any advance treatment is used with people in clinical trials, researchers work for many years to understand its effects on cancer cells in the lab and in animals. They also try to figure out the side effects it may cause.
Track 19: Innovations in Cancer Research and Oncology
Continuous Anticancer drug discovery and development is difficult to find a complete cure for cancer. Due to the drug resistance developed by tumour cells for existing treatments, this is becoming a mandatory approach to fight the disease.
Scientific investigations on inhibitors of checkpoint CHK1 can be another milestone for anticancer drug discovery approach.
Cancer cells are specifically dependent on molecular chaperones and related proteins that regulate homeostasis. These are promising targets for new anticancer therapies.
Deregulated apoptosis is hallmark of cancer and Bcl-2 family of proteins are pivotal to mediating the pathway of this process. Inhibiting their process can be a significant way for developing new anticancer drugs. Many plant sources are known to be important sources of novel anti-cancer properties.
The term ‘Cancer’ can be defined as the uncontrolled growth of cells in the body. It is an outcome of cascading events involving abnormal cell divisions. These cell divisions occur due to various biotic and abiotic factors. These factors may include physical exposure to certain substances or chemicals which are also termed as carcinogens; exposure to radiations that involve both ionizing and non-ionizing. Cancer is also known to be linked with some autoimmune diseases such as celiac disease, crohn’s disease. There are more than 200 types of cancer. Some diagnostic techniques are used to diagnose the cancer, cancer growth, affected area and severity of the disease such as MRI, CT Scan, PET scan, Ultrasound, some laboratory biochemical analysis tests, to detect the presence of excess levels of certain substances that may also be the cause of cancer.
Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place. When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumours.
Importance and Scope
Cancer Summit 2022 will be the best platform for all the scientist, radiologists, oncologists, research scholars, students who are working in this field to exchange their knowledge related to Cancer and oncology. This international event is an effort to find an alternative for invasive imaging technique against cancer like Liver Cancer, Brain Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Cancer in adults & cancer in children.
North America is the leading regional marketplace for cancer diagnostics with a part of approximately 40.7% of the general cancer diagnostics market in terms of income in 2020, shadowed by Europe which accounted for around 29.1% share in the market.
Cancer Research Centres:
A. K. Khan Healthcare Trust
Aalborg Hospital - Department of Oncology
Aarhus University Hospital - Department of Oncology
Abbotsford Cancer Centre
bramson Cancer Centre
ddenbrookes Oncology Centre
Aichi Cancer Centre
Albert Einstein Cancer Centre
Allan Blair Cancer Centre
Alvin J. Siteman Cancer Centre
Arizona Cancer Centre
Atlantic Cancer Research Institute
Azienda Ospedaliera Arcispedale S. Maria Nuova
Comprehensive Cancer Centre Ulm
Comprehensive Cancer Centre Vienna
Comprehensive Cancer Centre - Vratsa
Comprehensive Cancer Centre the Netherlands
Cork University Hospital: Cancer Centre
Country Dispensary for Oncological Diseases, Shumen
Cross Cancer Institute
Dan L. Duncan Cancer Centre
Dana-Farber/Harvard Cancer Centre
David H. Koch Institute for Integrative Cancer Research at MIT
Delhi State Cancer Institute
Department of Paediatric Haematology and Oncology
Dharmais Hospital - National Cancer Canter
District Dispensary for Oncological Diseases, Plovdiv
Dokuz Eylül University, Institute of Oncology
Duke Cancer Institute
Dundee Cancer Centre
Erasmus MC Daniel den Hoed Cancer Centre
European Institute of Oncology
Fakkous Centre for Cancer and Allied Diseases
Feist-Weiller Cancer Centre
Finsen Centre, Rigshospitalet - Department of Oncology
FN Brno - Department of Paediatric Oncology
Fondazione IRCCS Istituto Nazionale dei Tumori
Fox Chase Cancer Centre
Fraser Valley Cancer Centre
Fred and Pamela Buffett Cancer Centre
Fred Hutchinson Cancer Research Centre
Fudan University Shanghai Cancer Centre
Fundacion Instituto Valenciano de Oncologia (IVO)
Galway University Hospital: Cancer Services
General University Hospital in Prague
Georgetown Lombardi Comprehensive Cancer Centre
Georgia Regents University - Cancer Centre
Grand River Regional Cancer Centre
Gujarat Cancer & Research Institute / Gujarat Cancer Society
Harold C. Simmons Cancer Centre
Helsinki University Central Hospital
Henry Moore Institute of Oncology
Herbert Irving Comprehensive Cancer Centre
Herlev Hospital - Department of Oncology
Higashi Sapporo Hospital
Holden Comprehensive Cancer Centre
Hollings Cancer Centre
Hospital Ceske Budejovice - Comprehensive Cancer Centre
Hospital de Clínicas "Dr. Manuel Quintela"
Huntsman Cancer Institute
Major Cancer Associations Worldwide:
American Association for Cancer Research
Virginia Cancer Institute
American Brain Tumour Association
American Society of Paediatric Haematology/Oncology
Association of Cancer Physicians
American Childhood Cancer Organization
American Society of Clinical Oncology
Australasian Lung Cancer Trials Group
International Cancer Research Partnership (ICRP)
American Association for Cancer Research (AACR)
American Society of Clinical Oncology (ASCO)
International Agency for Research on Cancer (IARC)
Cancer Society of New Zealand
Irish Cancer Society
Australian Cervical Cancer Foundation
Medical Centre Cologne
Cancer Research UK
Australian Prostate Cancer Research
Peter McCollum Cancer Centre
The European Cancer Organization (ECCO)
German Cancer Research Centre
In Asia Pacific
Medical Excellence JAPAN
Japan Community Health care Organization Chukyo Hospital
Aichi Cancer Centre Hospital
Japanese Red Cross Nagoya Daiichi Hospital
Kyoto University Hospital
Dokkyo Medical University Hospital
Japan Hospital Association
Aizawa Hospital
Medical Excellence JAPAN
Japan Community Health care Organization Chukyo Hospital
Aichi Cancer Centre Hospital
Japanese Red Cross Nagoya Daiichi Hospital
Kyoto University Hospital
Dokkyo Medical University Hospital
Japan Hospital Association
Aizawa Hospital
University Hospital Kumamoto University
International Medical Centre of Japan
The Asia-Pacific Urogynecology Association
The Asia-Pacific Cancer Society Training
Asian Cancer Foundation India
The Max Foundation
Childhood Cancer International Netherlands
The Asia Pacific Prostate Society
Market Analysis Report
The cancer diagnostics market is expected to grow at a CAGR of 11.8% during the forecast period 2017-2023. There are several methods of diagnosing cancer today such as biopsy based, endoscopy based, imaging procedure, tumour cancer diagnostics and many more. Population affected with cancer is showing a tremendous growth during last few years, which create the requirement of advanced technology for diagnosis cancer on early stage. According to the American Cancer Society, in 2017, it is estimate that around 161,360 new cases of prostate cancer will be diagnosed and around 26,730 deaths occur owing to prostate cancer in the United States. Thus, many companies are involved in collaboration in order to provide better technology for diagnosis the cancer. In this regards, in January, 2015, Roche and Qualcomm Incorporated entered into a strategic collaboration to improve remote monitoring and management of patients with chronic disease.
The total cost of cancer therapeutics and medicines used in supportive care– measured at the ex-manufacturer price level before the application of rebates or other price concessions – reached $107 billion in 2015, representing an increase in constant dollars of 11.5% over the prior year.
Annual growth in the oncology drug market is expected to be 7.5 – 10.5 % through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes.
about $51.2 billion in 2017 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. It includes current issues and trends affecting the industry, costs and factors influencing demand. The report covers biological products in development, biological products in clinical trials, and currently marketed and late-stage development biologic cancer products.
